[8]JinM,LuH,LIJ,etal.Ramdomized3-armedphaseIIIstudyofS-1monotherapyversusS-1/CDDP(SP)versus5-FU/CDDP(FP)inpatients(pts)withadvancedgastriccancer(AGC):SC-101study.ProcAmScoClinOncol,2008,26:abstr4533. [9]孙燕石远凯《临床肿瘤内科手册》人民卫生出版社2009年5月第五版P846. [10]储大同《当代肿瘤...
S1治疗胃癌的国外进展 替吉奥治疗胃癌的进展 徐建明军事医学科学院307医院肿瘤中心 试验背景—替吉奥胶囊 替吉奥胶囊（S-1），是日本大鹏药品工业株式会社研制的一种口服氟脲嘧啶类衍生物。1999年在日本上市，在日本已取得胃癌、结直肠癌、头颈癌、肺癌、胰腺癌、乳腺癌、胆管癌等7个适应症。2005年，S-1获得SFDA批准...
肺部肿瘤39.2004S-1肺癌临床研究进展40.S-1合并顺铂晚期一线非小细胞41医院对象药品方案反应率後期臨床第Ⅱ相試験1stCDDP:60mg/m2TS-1:80mg/m247.3%(26/55)S-1CooperativeStudyGroup(肺癌学会2005)(ESMO2006)1stCDDP:60mg/m2TS-1:80mg/m232.7%(18/55)市立恵那病院(呼吸器学会2006)1stCDDP:60mg/m2TS-1:...
Randomized 3-armed phase III study of S-1 monotherapy versus S-1/ CDDP (SP) versus 5-FU/CDDP (FP) in patients (pts) with advanced gastric cancer (AGC): SC-101 study. J Clin Oncol. 2008;26(15):4533–4533. https:// doi.org/10.1200/jco.2008.26.15...
COC1/CDDP细胞;细胞背景资料:详见相关文献介绍;细胞传代方法:1:2-1:3传代;每周换液2-3次。;细胞生长特性:贴壁或悬浮,详见细胞说明书部分;细胞形态特性:详见细胞说明书;相关细胞有:UCLA RO-81A-1细胞、IFRS1细胞、DHL-6细胞 MDA-MB-361细胞;细胞背景资料:该细胞源自40岁女性乳腺癌的脑转移组织。;细胞传代方法...
Exosomic miR-155 transferred by human monocytes was capable of directly targeting TERF1 and affecting telomerase activity and telomere length in NBL, which is involved in the increased chemoresistance CDDP. This novel exosomic miR-21/ TLR8/NF-кB/exosomic miR-155/TERF1 axis suggests that ...
顺铂聚乳酸聚乙二醇纳米粒CDDP-PLA-PEG-NP隐形聚乳酸纳米载体颗粒载5-氟尿嘧啶两亲多糖纳米粒5-FU/DEX-g-PLA载药纳米微粒多功能化树状大分子包裹的金纳米颗粒Brucine/NGPC-NPs三甲基化壳聚糖卵清蛋白纳米粒载多西他赛和藤黄酸白蛋白纳米粒(DTX-GA-BSA NPs)环孢素A白蛋白纳米粒(CyA-HSA)藤黄酸白蛋白纳米粒(GA-...
TS-1 is a novel oral fluoropyrimidine anticancer agent and show synergism with CDDP. The objectives of this study were to determine the clinical toxicities... H Iwase,M Shimada,M Nakamura,... - 《Gan to Kagaku Ryoho Cancer & Chemotherapy》 被引量: 46发表: 2002年 Randomized Phase II trial...
S-1, an oral fluoropyrimidine, combined with carboplatin or cisplatin (CDDP) has shown no less efficacy than standard platinum doublet chemotherapy in Japanese NSCLC patients. However, the effectiveness in Chinese NSCLC patients is uncertain. We aimed to compare the efficacy...
Chemotherapy is one of the main strategies to treat cancer. Various chemotherapy drugs, such as doxorubicin (DOX), cisplatin (CDDP), camptothecin (CPT), and tirapazamine (TPZ), have clear therapeutic mechanisms and can have remarkable therapeutic effects. However, drug resistance may develop and to...